|
1. Texas attorney general probes alleged immunization 'incentives': 4 vaccine updates Full story
2. Lilly inks $1.1B gene therapy deal for hearing loss Full story
3. 2026 strategy check: Are your assumptions about care delivery still holding up? Get answers here.
4. FDA lifts hold on Intellia’s phase 3 trial for genetic nerve disease Full story
5. The future GLP-1 might be a gene therapy: Report Full story
6. Price isn't everything anymore — See how systems are redefining purchasing value, here.
7. Nebraska medical center helps launch biotech targeting Parkinson's Full story
8. Velsera names new CEO Full story
Becker's Learning Opportunities
9. How will healthcare's new power brokers reshape care delivery in 2026? Get answers here.
10. Patients want options earlier. The financing steps that strengthen ASC access and revenue here.
11. New healthcare survey reveals uneven application of cybersecurity best practices. Learn more here.
12. Interested in more? See Becker’s full lineup of
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
